Latest oppositions filed by Ferring B.v.

This table presents recent patent oppositions filed by Ferring B.v. against its competitors. It outlines key details of each case, including the patent title, filing date and the applicant. This information provides insights into the competitive landscape and highlights active disputes over patent grant within the industry.

Patent NumberTitleApplicantOpposition Date
EP3278809Safe Desmopressin AdministrationALLERGAN, INC.Aug 20, 2020
EP2854790Use Of N-Acetyl-5-Methoxytryptamine Or Analogues Thereof, For Promoting The Mechanism Of Implantation Of The Embryo And Related Compositions And Culture MediaARES TRADING SAMay 14, 2019
EP2381923Safe Desmopressin AdministrationACERUS PHARMACEUTICALS USA, LLCMay 1, 2019
EP2164877The Puro-Dhfr Quadrifunctional Marker And Its Use In Protein ProductionMERCK SERONO S.A.Sep 4, 2018
EP2442821Safe Desmopressin AdministrationACERUS PHARMACEUTICALS USA, LLCMar 12, 2018

The following table provides an overview of the latest patents of Ferring B.v. that has been opposed by its competitors. It provides an insight into the competitive landscape of the industry and highlights the patents that are subject to oppositions.

Patent NumberGrant DateTitleTotal Oppositions
EP3222272Nov 3, 2021Pharmaceutical Composition1
EP3144318Sep 23, 2020Recombinant Fsh Including Alpha 2,3- And Alpha 2,6-Sialylation1
EP2292252Aug 7, 2019Unitary Combination Of Fsh And Hcg1
EP3045471Mar 29, 2017Recombinant Fsh Including Alpha 2,3- And Alpha 2,6-Sialylation1